Levosimendan Improves Renal Function in Acute Decompensated Heart Failure: Cause and Clinical ApplicationEditorial to: “Levosimendan Improves Renal Function in Patients with Acute Decompensated Heart Failure: Comparison with Dobutamine by Yilmaz et al.”

[1] Heywood JT(2007)High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database J Card Fail 13 422-430

[2] Fonarow GC(2007)Worsening renal function and prognosis in heart failure: systematic review and meta-analysis J Card Fail 13 599-608

[3] Costanzo MR(2007)Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction Eur J Heart Fail 9 872-878

[4] Mathur VS(2006)Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? J Am Coll Cardiol 47 1-8

[5] Wigneswaran JR(2007)Classical inotropes and new cardiac enhancers Heart Fail Rev 12 149-156

[6] Wynne J(2007)Levosimendan improves renal function in patients with advanced chronic heart failure awaiting cardiac transplantation J Card Fail 13 417-421

[7] Damman K(2002)Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial Lancet 360 196-202

[8] Navis G(2002)Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN) Eur Heart J 23 1422-1432

[9] Voors AA(2007)Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial JAMA 297 1883-1891

[10] Damman K(2006)Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE Eur J Heart Fail 8 105-110

[1] Heywood JT(2007)High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database J Card Fail 13 422-430

[2] Fonarow GC(2007)Worsening renal function and prognosis in heart failure: systematic review and meta-analysis J Card Fail 13 599-608

[3] Costanzo MR(2007)Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction Eur J Heart Fail 9 872-878

[4] Mathur VS(2006)Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? J Am Coll Cardiol 47 1-8

[5] Wigneswaran JR(2007)Classical inotropes and new cardiac enhancers Heart Fail Rev 12 149-156

[6] Wynne J(2007)Levosimendan improves renal function in patients with advanced chronic heart failure awaiting cardiac transplantation J Card Fail 13 417-421

[7] Damman K(2002)Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial Lancet 360 196-202

[8] Navis G(2002)Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN) Eur Heart J 23 1422-1432

[9] Voors AA(2007)Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial JAMA 297 1883-1891

[10] Damman K(2006)Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE Eur J Heart Fail 8 105-110